Conversion of Proepithelin to Epithelins Roles of SLPI and Elastase in Host Defense and Wound Repair by Zhu, Jing et al.
Cell, Vol. 111, 867–878, December 13, 2002, Copyright 2002 by Cell Press
Conversion of Proepithelin to Epithelins:
Roles of SLPI and Elastase
in Host Defense and Wound Repair
ist that coordinate the phasing of otherwise incompati-
ble actions by diverse host cells in a wound (Martin,
1997; Singer and Clark, 1999).
Secretory leukocyte protease inhibitor (SLPI) is a pro-
tein named for its presence in epithelial secretions and
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short linker (Grutter et al., 1988). It was recently discov-2Program in Pharmacology
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Ashcroft et al. (2000) reported that SLPI-deficient miceNew York, New York 10021
have an impaired ability to heal wounds. Thus, despite7Amgen Incorporated
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inhibitors, there appears to be at least one action of a
serine proteinase that must be blocked before a wound
can heal at a normal rate. For the inhibition of this pro-Summary
teinase(s), SLPI appears to be nonredundant.
Epithelins (EPIs) or granulins are a group of 7 mutuallyIncreased leukocyte elastase activity in mice lacking
homologous, 6 kDa peptides, each characterized by 6secretory leukocyte protease inhibitor (SLPI) leads to
disulfide bridges. The function of EPIs has been elusiveimpaired wound healing due to enhanced activity of
despite their evolutionary conservation in plants, in-TGF and perhaps additional mechanisms. Proepi-
sects, fish, worms, and mammals (Avrova et al., 1999;thelin (PEPI), an epithelial growth factor, can be con-
Belcourt et al., 1993; Couto et al., 1992; Hong and Kang,verted to epithelins (EPIs) in vivo by unknown mecha-
1999) and isolation from diverse tissues and body fluidsnisms with unknown consequences. We found that
(Bateman et al., 1990; Belcourt et al., 1993; Shoyab etPEPI and EPIs exert opposing activities. EPIs inhibit
al., 1990; Sparro et al., 1997). Proepithelin (PEPI), alsothe growth of epithelial cells but induce them to se-
known as progranulin, PC-cell derived growth factor orcrete the neutrophil attractant IL-8, while PEPI blocks
acrogranin, was purified from the conditioned medianeutrophil activation by tumor necrosis factor, pre-
of transformed cell lines as an autocrine growth factorventing release of oxidants and proteases. SLPI and
(Baba et al., 1993; Xu et al., 1998; Zhou et al., 1993).
PEPI form complexes, preventing elastase from con-
Molecular cloning revealed that PEPI is comprised of
verting PEPI to EPIs. Supplying PEPI corrects the one copy of each of the EPIs plus a half copy of an
wound-healing defect in SLPI null mice. Thus, SLPI/ eighth EPI, with short peptides linking the EPI domains
elastase act via PEPI/EPIs to operate a switch at the (Bhandari et al., 1992; Plowman et al., 1992). NMR stud-
interface between innate immunity and wound healing. ies of a carp EPI revealed a compact globular structure,
leading to the suggestion that EPIs are strung in PEPI
Introduction like beads on a necklace (Hrabal et al., 1996). A PEPI
convertase presumably generates EPIs posttransla-
Wounding is a frequent threat to the life of the organism. tionally (Bateman and Bennett, 1998; Bhandari et al.,
The breach of epithelium triggers tissue mast cells, re- 1992; Plowman et al., 1992). However, it has not been
cruits leukocytes from the blood, and stimulates the established what enzyme(s) may convert PEPI to EPIs,
production of cytokines that activate them. Host survival under what regulation, or to what effect.
requires that leukocytes sterilize the wound and that The present work identifies interactions among three
epithelium closes it. However, the antimicrobial mole- molecules produced by leukocytes and/or epithelial
cules released by leukocytes—oxidants, proteases, and cells: elastase, PEPI, and SLPI. Only the binding of SLPI
antimicrobial peptides—can be inimical to epithelial cell to elastase was previously appreciated. Here, we de-
survival and proliferation. Control mechanisms must ex- scribe interactions between PEPI and SLPI and between
elastase and PEPI. Elastase digests PEPI exclusively
in the inter-EPI linkers and thus may be an important8Correspondence: ahding@med.cornell.edu
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component of a PEPI convertase. When bound by SLPI,
PEPI escapes from elastase-mediated digestion to EPI-
like fragments. PEPI and EPIs exert contrasting effects
on neutrophils and epithelial cells. Finally, PEPI can re-
place SLPI in restoring normal wound healing in SLPI
knockout mice, suggesting that a chief consequence of
SLPI deficiency is the ensuing deficiency of PEPI. Thus,
interactions among PEPI, SLPI, and elastase may act
as molecular switches to help coordinate host defense
and wound repair.
Results
SLPI Binds PEPI
SLPI inhibits the inflammatory responses of macro-
phages and monocytes to microbial products (Jin et al.,
1998, 1997; Wahl et al., 1997; Song et al., 1999). Seeking
the mechanism, we reasoned that mononuclear phago-
cytes are likely to express a molecular target(s) of SLPI.
We chose a yeast two-hybrid approach to identify SLPI
binding proteins. Mouse SLPI is a 131 amino acid protein
with an N-terminal 25-residue signal peptide (Figure 1A).
The mature sequence (aa 26–131) was used as the bait
in fusion with the DNA binding domain of the yeast
transcriptional activator, GAL4. The cDNA library was
constructed from a mouse bone marrow macrophage
cell line (HeNC2) and expressed in fusion with the activa-
tion domain of GAL4 (GAL4-AD). Four million yeast co-
transformants were analyzed for histidine auxotrophy
and -galactosidase activity. Twenty-seven clones
showed strong phenotypes in both assays. BamHI and
EcoRV digests (Figure 1B) assigned these 27 clones to 3
sequences. Sequencing confirmed that 21 of the clones
Figure 1. PEPI Binds SLPI in Yeastencoded the same partial cDNA from mouse PEPI, com-
(A) Domains in SLPI and preproepithelin. Mouse SLPI is composedprising 1180 bp of the ORF and 338 bp of the 3 UTR
of a secretory signal peptide (aa 1–25) and N- (aa 26–55) and C-terminal(Figure 1A, underlined). An additional clone consisted
(aa 56–131) domains. Mouse PEPI contains a secretory signal pep-
of a shorter piece of PEPI cDNA (clone 18 in Figure 1B). tide (aa 1–17) and 7.5 EPI domains, 7 of which are designated alpha-
The PEPI sequences were in frame with GAL4-AD. The betically. The fragment identified in two-hybrid screening is under-
PEPI-SLPI interaction was confirmed in yeast and its lined.
(B) BamHI and EcoRV digestion of 27 positive clones revealed 3specificity demonstrated (Figure 1C).
fragmentation patterns. The DNA markers (M) are HindIII digestPEPI contains 90 Cys residues that must form 45 cor-
and 123 bp ladders.rect disulfides. Thus, it is not surprising that we were
(C) Confirmation that PEPI and SLPI interact in yeast. Fusion of PEPI
unable to produce soluble, monomeric, intact PEPI and and SLPI to GAL4 activation and binding domains (AD and BD), respec-
EPIs in E. coli. However, a baculovirus-insect cell ex- tively, was compared to a positive control with p53 and SV40-T, nega-
pression system yielded EPI A in trace amounts and EPI tive controls with PEPI alone and SLPI alone, and non-specific controls
with PEPI and Gal4-BD or PEPI and lamin C. Positive interactionsB in somewhat larger amounts (Figure 2A). Mouse and
permitted growth without histidine and expression of LacZ.human PEPIs produced by insect cells were recovered
mostly as degradation products (not shown). Recipro-
cally, mammalian COS-1 (not shown) and HEK293 cells
(Figure 2A) produced stable PEPI but not EPIs (not gether in amounts proportionate to the quantity of
cDNAs used for transfection.shown). Based on this experience, we proceeded to
characterize the SLPI-PEPI interaction in vivo in trans- To test if the SLPI-PEPI complex exists in vivo, we
examined normal human bronchoalveolar lavage (BAL)fected mammalian cells and in vitro using recombinant
proteins purified from human and insect cells for PEPI fluid samples because both SLPI and PEPI are strongly
expressed in airway epithelium (Abe et al., 1991; Danieland EPIs, respectively.
We first cotransfected mouse SLPI and FLAG-tagged et al., 2000). PEPI was immunoprecipitated from the
BAL fluids collected from two individuals, and SLPI wasmouse PEPI into COS-1 cells (Figure 2B) and human
SLPI and FLAG-tagged human PEPI into HEK293 cells detected in the PEPI immunoprecipitates (Figure 2D).
Thus, the SLPI-PEPI complex is physiologic.(Figure 2C). The conditioned media were immunoprecip-
itated with anti-FLAG antibody to bring down PEPI and Next, we asked which part of PEPI binds SLPI (for the
order of EPIs in PEPI, see Figure 1A). EPIs G and F werethen Western blotted with anti-SLPI antibody. For both
mouse and human protein pairs, SLPI coimmunoprecipi- absent in the partial PEPI sequences isolated as SLPI
binding proteins in yeast (Figure 1A) and thus were dis-tated with PEPI. The two proteins were recovered to-
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869
Figure 2. SLPI Interacts with PEPI but not
EPIs In Vitro and In Vivo
(A) Recombinant human (H) and mouse (M)
PEPI were expressed in HEK293 cells. Human
recombinant EPI A and B were expressed in
insect cells. All 4 proteins were purified from
conditioned media.
(B) and (C) SLPI coimmunoprecipitated with
PEPI from the conditioned media of cotrans-
fected mammalian cells.
(B) Mouse proteins in COS-1 cells.
(C) Human proteins in HEK293 cells. p, plas-
mid; v, vector; IP, immunoprecipitation; WB,
Western blot; -S, anti-SLPI antibody;
-FLAG, antibody to the FLAG-tag that is
fused with PEPI.
(D) SLPI was detected in the PEPI immuno-
precipitates from two human bronchoal-
veolar lavage (BAL) fluids.
(E) SLPI coimmunoprecipitated with PEPI but
not with EPI A or B in solutions of the pure
recombinant proteins. PEPI, EPI A and EPI B
were FLAG-tagged. A, human EPI A; B, hu-
man EPI B; S, human SLPI; P, human PEPI.
pensable for the interaction. We made a series of mouse of 4 well-known SLPI-targeted serine proteinases could
cleave PEPI: elastase and cathepsin G from human neu-PEPI C-terminal deletion mutants and cotransfected
these mutants with SLPI into COS-1 cells. Truncation trophils and trypsin and chymotrypsin from bovine pan-
creas. Only elastase and chymotrypsin hydrolyzed re-mutants containing EPIs G, F, B, A, and C coimmuno-
precipitated with SLPI (not shown), indicating that EPIs combinant human PEPI (Figure 3A). Mouse SLPI is an
effective inhibitor of elastase and chymotrypsin, but aD and E are not required for binding of PEPI to SLPI. The
expression level of further truncation mutants dropped relatively poor inhibitor of cathepsin G and trypsin (Zitnik
et al., 1997). Similarly, human SLPI has Ki values fordramatically as the deletion proceeded, making it diffi-
cult to interpret coimmunoprecipitation results with the elastase, chymotrypsin, cathepsin G, and trypsin of 0.3,
2.4, 10, and 44 nM, respectively (Wright et al., 1999;shorter forms. When FLAG-tagged recombinant human
EPI A or EPI B was incubated with recombinant human Zitnik et al., 1997). These results suggested that those
proteinases that SLPI readily inhibits are the ones mostSLPI at an equimolar ratio (Figure 2E) or at a molar ratio
of A (or B):SLPI::1:5 (not shown), SLPI was not detected capable of hydrolyzing PEPI. As expected from these
observations, human and mouse SLPI did block thein EPI immunoprecipitates or vice versa. Yet, in a similar
assay, holo-PEPI and SLPI each reciprocally coimmuno- cleavage of human PEPI by elastase, human SLPI being
the more potent (Figure 3B). To see whether binding ofprecipitated the other (Figure 2E). The results indicate,
first, that PEPI and SLPI bound each other without the SLPI/PEPI can also contribute to the protection of PEPI
from elastase, we took advantage of a SLPI active-sitemediation of additional proteins, and second, that EPIs
A, B, D, E, F, and G were each not necessary or not mutant (L72K) that is no longer inhibitory to elastase
(Eisenberg et al., 1990), but is still capable of bindingsufficient for stable interaction with SLPI. It was not
excluded that SLPI might bind uniquely to EPI C. How- SLPI (not shown). SLPIL72K (but not a control protein,
BSA) protected PEPI (but not a control substrate, tu-ever, this seems unlikely, since EPI C is highly homolo-
gous (87% among EPIs) to the 6 EPIs to which SLPI did bulin) from elastase digestion (Figure 3C). Thus, SLPI
can protect PEPI from digestion by two distinct mecha-not bind. Instead, SLPI appears to bind to inter-EPI linker
region(s) of PEPI or to a site only present in PEPI’s nisms: binding to a serine proteinase and binding to PEPI.
Neutrophil elastase is a candidate to contribute totertiary structure.
PEPI convertase activity, because elastase is released
in large quantities during infection and inflammation atElastase Can Serve as Part of a PEPI Convertase
Because SLPI binds PEPI but not EPIs, PEPI converts PEPI-producing sites. At these same sites, elastase is
also likely to encounter its physiologic regulator, SLPI.to EPIs, and SLPI inhibits serine proteinases, we postu-
lated that SLPI might block conversion of PEPI to EPIs If elastase can participate in the processing of PEPI
to EPIs, it should not cleave PEPI within EPI domains.by either or both of two mechanisms: (1) binding to
and blocking a serine proteinase component of a PEPI Indeed, EPI A and B were resistant to elastase (Figure
3D). In contrast, PEPI itself was cleaved by elastase inconvertase and (2) binding to and blocking cleavage
sites in PEPI. To test these ideas, we first asked if any a concentration- and time-dependent manner, yielding
Cell
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Figure 3. SLPI Prevents Conversion of PEPI
to EPIs by Elastase
(A) Select serine proteinases cleave PEPI.
Anti-FLAG Western blot of recombinant
mouse PEPI (100 ng/lane) incubated with
elastase (0.3 U/ml), chymotrypsin (12.5 g/
ml), cathepsin G (0.1 U/ml), or trypsin (1.25
g/ml) for the indicated times. Fold protein-
ases, multiples of the indicated proteinase
concentrations; Ki, reported inhibitory con-
stants of mouse SLPI for the indicated pro-
teinases (Zitnik et al., 1997).
(B) SLPI protects PEPI from proteolysis. Hu-
man or mouse SLPI inhibits proteolysis of
mouse PEPI (100 ng/lane) by elastase. Sam-
ples were incubated at 37C for 30 min and
Western blotted with anti-FLAG antibody.
(C) Mutant SLPI protects PEPI from proteoly-
sis. Mutant SLPI lacking anti-elastase activity
(2 M) inhibits elastase-mediated proteolysis
of PEPI but not of mouse brain tubulin.
SLPIwt, wild-type human SLPI (40 nM);
SLPIL72K, human SLPI Leu72Lys mutant (2
M); BSA, bovine serum albumin (2 M). Pro-
epithelin or tubulin (100 ng/lane) were incu-
bated with 0.1 U/ml of human elastase with
indicated reagents at 37C for 15 min and
Western blotted with anti-PEPI or anti-tubulin
antibody.
(D) Elastase cleaves PEPI but not EPIs. Pure
recombinant human EPI A and B (5 g each)
were resistant to digestion by elastase (37C,
60 min), but pure recombinant PEPI (5 g)
was cleaved to discrete fragments as re-
vealed by SDS-PAGE followed by Coomassie
blue staining.
(E) Elastase cleaves PEPI within inter-EPI
linkers. N-terminal sequences of the indi-
cated PEPI fragments were determined by
automated Edman degradation. Arrows indicate cleavage sites, all of which were in inter-EPI linkers. Each arrowhead marks the cleavage
site that generated the N terminus of an individual polypeptide. The identified N-terminal sequences of elastase fragments are underlined.
Residues contained in EPI domains as purified from natural sources are in bold.
discrete fragments. To determine elastase cleavage tions between 50–100 nM (Figure 4A), while recombinant
human EPI B inhibited the growth of the same two cellsites, PEPI fragments from an extensive elastase diges-
tion (3 U/ml, 18 hr) were subjected to N-terminal se- lines, with 50% inhibitory concentrations of 1–3M (Fig-
ure 4B). These results indicated that we had succeededquencing. Fifteen identifiable N-terminal sequences of
8 independent gel slices from the region of apparent in producing bioactive PEPI and EPI B, despite the large
number of disulfide bonds.molecular mass 13 to 22 kDa (where recombinant EPIs
migrate) all fell in linker regions of PEPI (Figure 4E). No Considering that elastase, a neutrophil product, can
convert PEPI to EPI-like fragments, we asked if EPIscleavage site was found within any epithelin domain.
Virtually complete conversion of PEPI to epithelin-sized could trigger epithelial cells to release IL-8, the major
chemokine that attracts neutrophils (Baggiolini andfragments was also observed with protein chip mass
spectrometry (Ciphergen system, not shown). There- Clark-Lewis, 1992). Indeed, both A549 and SW-13 cells
produced large amounts of IL-8 in response to EPI Bfore, elastase cuts PEPI in the inter-EPI regions. While
elastase thus can act as at least part of a PEPI con- (Figure 4C). Strikingly, PEPI was completely inactive in
this assay. Because of the limited supply of recombinantvertase, additional proteolytic events would be required
to produce precisely the same boundaries identified in EPIs, EPI A could not be tested and a maximally effective
concentration of EPI B was not defined. However, theEPIs as they have been purified from tissues.
concentration-response relationship was in the same
range as for inhibition of epithelial cell proliferation (Fig-Contrasting Effects of PEPI and EPIs
on Epithelial Cells ure 4B). Thus, EPI B can promote epithelial cytostasis
and neutrophil recruitment, while PEPI, in contrast, pro-PEPI is a growth factor for cells of epithelial origin and
various tumors (Zanocco-Marani et al., 1999; Zhou et motes epithelial proliferation without eliciting produc-
tion of IL-8. IL-8 inducing activity was also observed inal., 1993). In contrast, EPI A and B inhibited growth of
epithelial cells. In our hands, recombinant human PEPI an elastase digest of PEPI (Figure 4D), suggesting that
at least some EPI-like bioactivity can be generated fromstimulated the proliferation of two human epithelial cell
lines, A549 and SW-13, with 50% effective concentra- PEPI by elastase alone.
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Figure 4. Contrasting Effects of PEPI and EPI
B on Epithelial Cell Proliferation and Chemo-
kine Release
Results are means  SEM for triplicate cul-
tures in 1 representative experiment of 3 (A,
B, and C). Some error bars fall within the
symbols.
(A) Concentration-dependent stimulation of
A549 and SW-13 cell proliferation by human
PEPI.
(B) Concentration-dependent inhibition of
A549 and SW-13 cell proliferation by human
EPI B.
(C) Release of IL-8 from A549 and SW-13 cells
in response to EPI B but not PEPI.
(D) Induction of IL-8 by elastase-digested
PEPI. Results are means  SEM (n  7). *,
p 	 0.03 compared with controls.
Contrasting Effects of PEPI and EPIs venting the release of proteinases that digest PEPI. Ac-
cordingly, we examined proteinase activity in the condi-on Neutrophils
Neutrophils adherent to proteins of extracellular matrix tioned media of activated neutrophils. PEPI almost
completely abolished the TNF-triggered release of ca-are triggered by inflammatory stimuli like tumor necrosis
factor (TNF) to generate large quantities of reactive oxy- sein-degrading proteinases (including elastase) from
neutrophils (Figure 6A). The conditioned media from ac-gen intermediates (ROI) (Nathan, 1987) and to release
their granule contents, including elastase (Taggart et al., tivated neutrophils also digested PEPI, and the ability
of these media to do so was inhibited both by SLPI and2000). Accordingly, we tested the effect of PEPI, EPIs,
and SLPI on the TNF-induced respiratory burst and re- by the pan serine protease inhibitor diisopropyl fluoro-
phosphate (DFP) (Figure 6B). Of the three serine protein-lease of proteinases by human neutrophils adherent to
a surface coated with serum proteins. As a control, we ases known to be released by activated PMN, cathepsin
G does not digest PEPI and proteinase 3 is not inhibitedalso stimulated neutrophils with a nonphysiologic ago-
nist, phorbol myristate acetate (PMA). by SLPI, while elastase both digests PEPI and is inhib-
ited by SLPI. Thus, the PEPI-digesting activity releasedPEPI inhibited the respiratory burst triggered by TNF
(Figure 5A, b). This did not reflect interference with the by stimulated human neutrophils was attributable to ser-
ine proteinases; PEPI blocked their release and elastasephagocyte oxidase (phox) or with the assay, because
PEPI had no effect on the amount of H2O2 detected in the is likely to be the major PEPI-digesting activity released
by activated neutrophils.medium in response to PMA (Figure 5A, a). In contrast to
results with PEPI, neither EPI A nor B was able to block PMA and TNF trigger adherent neutrophils to spread
and establish podosomes and focal adhesions in con-the TNF-induced respiratory burst (Figure 5A, c). The
triggering of adherent neutrophils by cytokines displays tact with the extracellular matrix (Fuortes et al., 1993),
as illustrated in Figure 6C (compare c and e to controla characteristic lag period involving cytoskeletal reorga-
nization. Reagents that disrupt signaling events during in a). PEPI alone had no effect on neutrophil morphology
(Figure 6C, b) nor on the spreading elicited by PMAthe lag period can abort the respiratory burst even when
added after the stimulus, provided that the respiratory (Figure 6B, d). However, PEPI abolished cell spreading
but not cell adherence in response to TNF (Figure 6C,burst has not yet commenced (Nathan et al., 1989, 1987).
Indeed, PEPI abolished the TNF-induced respiratory f). These results suggest that PEPI spares early events
following TNF signal transduction that lead to cell adher-burst even when added 30 min after TNF (Figure 5B, b).
In contrast, PEPI had no effect when added during an ence but interferes with later events that lead to cell
spreading, the respiratory burst and degranulation.ongoing respiratory burst (Figure 5B, c). These results
suggested that PEPI inhibited neutrophil activation by These characteristics directed attention to Pyk2, a tyro-
sine kinase expressed in neutrophils that appears toperturbing intracellular signaling events initiated after
TNF binds to its receptor. mediate TNF-induced cell spreading and respiratory
burst (Fuortes et al., 1999). To test whether PEPI inter-Exogenous SLPI exerts a modest inhibitory effect on
the TNF-induced respiratory burst (Grobmyer et al., feres with Pyk2 phosphorylation induced by TNF, neu-
trophils were preincubated with PEPI for 30 min before2000) as illustrated in Figure 5B (a and b). SLPI and PEPI
augmented each other’s neutrophil-inhibitory effects TNF stimulation. The activation of Pyk2 in the PMN ly-
sates was inferred by Western blot with antibodies spe-(Figure 5C).
PEPI’s inhibition of neutrophils may extend to pre- cific for phosphotyrosines 402, 580, and 881. PEPI (but
Cell
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Figure 5. PEPI and SLPI but not EPIs Sup-
press the TNF-Induced Respiratory Burst of
Adherent Human Neutrophils
Results are means  SEM for nmol H2O2 pro-
duced by 1.5 
 104 cells/well in triplicate cul-
tures in 1 representative experiment of 3-6
(A), 3 (B), or 3 (C) performed. Most error bars
fall within the symbols.
(A) Human PEPI (b) but not EPIs A or B (c)
inhibited the respiratory burst triggered by
TNF, but had no effect on the respiratory
burst triggered by PMA (a).
(B) Effect of delayed addition of PEPI, SLPI,
or the combination of PEPI  SLPI on the
TNF-triggered respiratory burst. PEPI and/or
SLPI were added with TNF (a) or 30 min (b)
or 100 min (c) after TNF as marked by arrows.
(C) SLPI and PEPI augment each other’s in-
hibitory effect on TNF-induced neutrophil ac-
tivation. Shown is cumulative H2O2 release
120 min after addition of TNF (100 ng/ml),
PEPI (0.3 M), and/or SLPI (3 M). Results
are from one of 3 similar experiments.
not ovalbumin, a protein control) abolished TNF-induced SLPI-deficient tissues to counter proteolysis by serine
proteinases, perhaps arising from the infiltrating leuko-tyrosine phosphorylation of Pyk2 (Figure 6D).
cytes. The discovery of a SLPI/PEPI/elastase axis and
the dual roles of PEPI in promoting epithelialization andRecombinant PEPI Restores Normal Wound
Healing in SLPI-Deficient Mice blocking activation of neutrophils prompted us to ask,
first, if endogenous PEPI is expressed during woundSLPI null mice have impaired healing of wounds accom-
panied by increased leukocyte infiltration and elevated healing, and second, if exogenous PEPI can restore
normal wound healing in SLPI null mice.elastase activity (Ashcroft et al., 2000). Delayed re-epi-
thelialization is presumably related to an inability of Figure 7A shows that PEPI was constitutively ex-
Interactions of Proepithelin, SLPI, and Elastase
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Figure 6. PEPI Inhibits Neutrophil Degranu-
lation, Pyk2 Phosphorylation, and Spreading
(A) Proteinase activity in the conditioned me-
dia of neutrophils 180 min after exposure to
TNF (100 ng/ml) and/or PEPI (1 M). Proepi-
thelin inhibited TNF-induced degranulation
without affecting cell viability, measured as
release of the cytosolic enzyme lactate dehy-
drogenase (LDH). Total activity corresponded
1.66 (A490–A600).
(B) DFP inhibits PEPI degradation by PMA
stimulated neutrophils. Human FLAG-tagged
PEPI (100 ng/lane) was incubated with condi-
tioned medium from PMA simulated neutro-
phils at 37C for 30 min in the presence of
DFP (2 g/ml) or human SLPI (10 nM). Sam-
ples were Western blotted with anti FLAG an-
tibody.
(C) Conversion of neutrophils from spherical (a
and b) to spread forms (c–f) 60 min after addi-
tion of PMA (100 ng/ml) (c and d) or TNF (100
ng/ml) (e and f). PEPI (1M) selectively arrested
spreading induced by TNF (f). Bar is 10 m.
(D) Suppression of TNF-induced tyrosine
phosphorylation of Pyk2 in neutrophils. Cell
lysates (50 g) from PEPI or ovalbumin (OVA)
pretreated (30 min) and TNF-stimulated (45
min) neutrophils were fractionated on SDS-
PAGE and Western blotted with indicated an-
tibodies.
pressed in mouse cutaneous tissue and that PEPI tran- in the present experiments, in which the bait contains
8 disulfide bonds, and PEPI, the binding protein wescripts were markedly increased upon wounding, as
identified, is normally glycosylated and contains 45 di-reported for SLPI in wild-type mice (Ashcroft et al. 2000)
sulfides. Nonetheless, there is precedent for successfuland confirmed here. Wounding induced PEPI to the
application of yeast two-hybrid screening to secretorysame extent in the SLPI ko mice as in wild-type mice
proteins bearing disulfides (McQuibban et al., 2000;(Figure 7A).
Weinzimer et al., 2001; Zhu and Kahn, 1997). The forma-We next assessed the effect of PEPI on wound healing
tion of a complex between SLPI and PEPI was evidentin the model used by Ashcroft et al. (2000). Four 1 cm
in over 80% of the yeast clones characterized and wasincisional wounds were made through the skin and pan-
confirmed by coimmunoprecipitation from pure solu-niculus carnosus on the dorsum of each SLPI null or
tion, from cells, and from human lung fluid. The potentialmatched wild-type mouse. Immediately before wounding,
physiologic relevance of complex formation betweenthe area to be incised was injected subcutaneously with
SLPI and PEPI is supported by their overlapping tissuerecombinant rat SLPI, recombinant mouse PEPI, or PBS
distribution. As noted, both are expressed in airway epi-vehicle control. Three days later, biopsies were taken
thelium. SLPI has also been detected in saliva (Thomp-across the widest portion of the wound, sectioned, and
son and Ohlsson, 1986), cervical (Helmig et al., 1995),analyzed by morphometry (Figure 7B and 7C). In wild-
nasal and bronchial mucus (Hutchison, 1987; Lee et al.,type mice, application of SLPI and PEPI had no effect on
1993), and seminal fluid (Ohlsson et al., 1995). In situthe rate of healing (not shown). In contrast, the retarded
hybridization has shown that PEPI is expressed in thehealing of SLPI-deficient mice was fully normalized not
epithelia of skin, lung, kidney, uterus, and cervix (Danielonly by recombinant SLPI, but just as effectively by
et al., 2000); we have confirmed its expression in humanrecombinant PEPI (Figure 7B and 7C). This suggested
lung and mouse skin. Finally, we have cloned both SLPIthat a primary consequence of SLPI deficiency was that
(Jin et al., 1997) and PEPI from macrophages.intact PEPI became rate-limiting for healing, despite the
Mutation analysis and the crystal structure of humanincrease in its local synthesis.
SLPI with a target proteinase (Grutter et al., 1988) local-
ized SLPI’s anti-proteinase site to the C-terminal do-
Discussion main, where Leu72-Met73 are displayed in a loop that
interacts with the catalytic triad of serine proteinases
Yeast two-hybrid screening is a well-established method (Eisenberg et al., 1990). Likewise, we found that SLPI’s
for studying protein-protein interactions involved in intra- C-terminal domain selectively interacts with PEPI (not
cellular events (Chien et al., 1991). The method is rarely shown). The interaction between SLPI and PEPI may be
used to study interactions between proteins that are based in part on electrostatics. Human SLPI bears 12
secreted, in part because glycosylation and disulfide net positive charges and PEPI 5 net negative charges.
bond formation might not be correctly reproduced in While the N-terminal domain carries half of SLPI’s posi-
tive charges, they are scattered. In contrast, those inyeast cytosol. This concern was particularly pertinent
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opposite face. Since SLPI and PEPI are both produced
constitutively by epithelial cells, they can be expected
to form a complex before inflammation triggers an influx
of elastase. If a given molecule of SLPI can bind PEPI
and elastase at the same time, then pre-existent SLPI-
PEPI complexes may retain the ability to inhibit elastase.
This is supported by our finding that PEPI-complexed
SLPI retained the ability to protect extracellular matrix
proteins fibronectin, vitronectin, and collagen type I from
digestion by elastase (not shown). Our studies also sug-
gest that SLPI most likely binds PEPI at inter-EPI linker
peptides, 5 of which contain negative charges. Thus,
one molecule of PEPI may be decorated with several
molecules of SLPI. The N-terminal domain of SLPI binds
glycosaminoglycans (Mellet et al., 1995; Ying et al., 1994)
and in this way SLPI may serve as a bridge to localize PEPI
to epithelial surfaces. This could augment the bioactivity of
PEPI. Binding to epithelial glycosaminoglycans may also
position SLPI to protect the glycosaminoglycans from pro-
teolytic shedding during inflammation (Park et al., 2000).
This work describes an unusual sitation in which a
protein precursor (proepithelin) and its processed frag-
ments (epithelins) are both bioactive and yet have con-
trasting or even opposing physiological functions. PEPI,
but not EPIs, potently and specifically inhibited TNF-
induced signal transduction in neutrophils, thereby
blocking cell spreading, Pyk2 tyrosine phosphorylation,
oxidant production, and proteinase release. PEPI pro-
motes the proliferation of epithelial cells (Figure 4A) (He
and Bateman, 1999; Xu et al., 1998; Zhang and Serrero,
1998; Zhou et al., 1993). PEPI is also secreted by the
trophoectoderm and stimulates the development of the
mouse preimplantation embryo (Diaz-Cueto et al., 2000).
Mitogenic actions of PEPI are subserved by its activa-
tion of MAP kinase and phosphatidylinositol 3-kinase
(Zanocco-Marani et al., 1999). In contrast, EPI B, but not
PEPI, inhibited epithelial cell proliferation and induced
epithelial cells to secrete the major chemokine for neu-
trophils, IL-8. Defensins, small antimicrobial peptides
released by activated neutrophils, can also induce IL-8
production by epithelial cells, but this effect is blocked
by the formation of complexes between defensins and
1-proteinase inhibitor (van Wetering et al., 2000).Figure 7. Impact of PEPI on Wound Healing
In short, EPIs boost inflammation, while PEPI antago-(A) Increased expression of PEPI and SLPI in wounds of wild-type
mice, and of PEPI in wounds of SLPI knockout (KO) mice. Wounds nizes inflammation and promotes re-epithelialization
were collected 3 days after incision and subjected to Northern blot. and wound healing. Any factor that controls the conver-
(B) Healing in a SLPI KO mouse. Wounds treated with SLPI (1 g) sion of PEPI to EPIs may thereby act as a biological
or PEPI (a, 1 g; b, 5 g) healed faster than PBS-treated controls. switch that helps regulate the transition between stages
(C) Administration of PEPI improves wound healing in SLPI KO mice.
of wound healing. Our results suggest that elastase mayDay 3 sections of the wound lesion treated with PBS (control), SLPI
be an important component of a PEPI convertase in(1 g/site), or PEPI (1 g/site) were scored for the width of wound
neutrophil-rich sites, and as such, may act as part of aor wound area. Means  SEM are shown for the number of wounds
indicated. Significance was assessed by ANOVA followed by Fish- biological switch.
er’s test. *, p  0.001; **, p 	 0.001; #, p  0.004; ##, p  0.002. SLPI potentially protects PEPI from elastase by two
(D) A model of interactions of SLPI, PEPI, and elastase relevant to distinct mechanisms: binding the substrate and binding
early (host defense; red) and late (host recovery; green) events in the proteinase. Elastase digests PEPI specifically in the
wound healing. For simplicity, only factors studied in this report are
inter-EPI regions, which is where SLPI appears to bind.shown. See Discussion.
Binding to the inter-EPI linkers may allow SLPI to protect
PEPI from convertases that SLPI does not directly in-
the C-terminal domain of human SLPI (R58, R59, K60, hibit. PEPI convertases other than elastase could be
K63, K87, R88, K91, and K106) are clustered in a patch postulated, since EPIs have been purified from unin-
on the surface opposite the proteinase binding loop flamed tissues. However, all mammalian tissues are vas-
(Grutter et al., 1988). The basic patch is conserved in cularized, and even perfused vasculature retains adher-
mouse SLPI. This suggests that SLPI’s C-terminal do- ent leukocytes. Monocytes, which contain elastase,
emigrate constitutively into all tissues. Finally, mast cellsmain may bind elastase on one face and PEPI on the
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are ubiquitously distributed around blood vessels and the bronchial epithelium (McElvaney et al., 1992). Fur-
within the epithelia of skin, lung, and airway. Mast cells ther, these findings raise the possibility that healing of
contain an elastase-like proteinase (Caughey, 1994). refractory wounds might be promoted by the application
Thus, lysates of virtually all tissues will contain elastase of PEPI and SLPI in combination.
or elastase-like proteinases. That elastase is a compo-
Experimental Proceduresnent of the major PEPI convertase is further suggested
by the finding that elastase-digested PEPI exhibited EPI-
Yeast Two-Hybrid Screening and cDNA Cloning
like activity. However, elastase-independent PEPI con- A C3H/HeN mouse bone marrow derived macrophage cell line,
vertases may also exist. This question may be clarified HeNC2 (Jin et al., 1997), was used for construction of a leukocyte
by comparing the amounts of EPIs that can be extracted cDNA library in the phagemid vector, pAD-GAL4 (Stratagene). The
bait construct, pBD-GAL4-SLPI, contains a truncated mouse SLPIfrom tissues of wild-type and elastase-deficient mice
ORF (aa 26–131). Screening followed the Hybri-ZAP kit protocol(Belaaouaj et al., 1998).
(Stratagene). Briefly, YRG-2 yeast harboring pBD-GAL4-SLPI wereWhile epithelial cell-derived PEPI and SLPI have been
transformed with the pAD-GAL4-HeNC2 cDNA library and grown onunderstood to contribute to the homeostasis of epithe-
plates lacking histidine. Clones recovered from His plates were
lium in unrelated ways, the present work suggests that analyzed for -galactosidase activity. Plasmid DNAs rescued from
they form a complex which may preserve, enhance, or individual His/-gal clones were subjected to restriction enzyme
enable bioactivities previously ascribed to each. More- digestion analysis and DNA sequencing. The partial PEPI ORF de-
rived from a His/-gal clone was labeled with [32P]-dCTP to screenover, the present work suggests that the SLPI-PEPI-
the HeNC2 cDNA phage library and clone full-length mouse PEPIelastase axis may help reconcile mutually antagonistic
cDNA. To clone human PEPI and SLPI, primers flanking the ORFsbiochemistries of antimicrobial action, tissue debride-
were used for RT-PCR with total RNA of A549 cells as template.
ment, and tissue regeneration during wound repair and
other forms of inflammation at epithelial surfaces (Hunt, Protein Expression, Purification, and Analysis
1990; Mashimo et al., 1996). Figure 7D outlines a specu- We produced human PEPI (aa 18–593), human EPIs A (aa 281–337)
and B (aa 206–261), and mouse PEPI (aa 18–589) each with anlative scenario for wound healing that deals only with the
N-terminal FLAG-6xHis tag, secretion being driven by the humanfindings in this report without discounting the important
PEPI signal peptide (aa 1–17). Recombinant baculovirus was ob-roles of other molecules such as TGF (Ashcroft et al.,
tained by recombination of BaculoGold DNA (Pharmingen) and1999), plasmin (Romer et al., 1996), and fibrinogen (Drew pVL1393 vector-based constructs, amplified in Sf9 cells, and used
et al., 2001). In epithelia in the steady state, SLPI is to infect Hi5 cells (Invitrogen) in suspension. Recombinant human
abundant, elastase-like proteinases are scant, and PEPI PEPI was also expressed by HEK293 cells stably transfected
with pTK-hygromycinR and pCMV1-FLAG-6xHis-PEPI (aa 18–593).is intact. PEPI inhibits the activation of the few neutro-
Transfectants were selected and maintained in 100 g/ml hygro-phils that find their way into healthy epithelia and pro-
mycin (Sigma, MO). Cells were grown to 90% confluence in Dulbec-motes epithelial regeneration to replace cells that are
co’s minimum Eagle’s medium (DMEM) with 10% fetal bovine serum,shed. With injury, epithelial cell production of SLPI and
washed twice with phosphate buffered saline (PBS), and cultured
PEPI declines. Mast cells and immigrant leukocytes re- in serum-free DMEM for 4 days. Conditioned media were concen-
lease proteinases that convert PEPI to EPIs. EPIs restrict trated by ammonium sulfate precipitation and purified by Ni-NTA
premature epithelial repair (that is, wound closure before (Qiagen) affinity chromatography. The imidazole-eluted proteins
were dialyzed against 20 mM ammonium bicarbonate, lyophilized,sterilization) while promoting the release of IL-8 or its
and reconstituted in sterile PBS. Recombinant human and mousefunctional equivalents in the mouse, which elicits the
SLPI were from Amgen (Thousand Oaks, CA). Pure, recombinantrecruitment of more neutrophils to fight infection. Oxi-
human or mouse protein (PEPI or SLPI) was injected into rabbits todants released by neutrophils inactivate SLPI (Carp and
raise antisera.
Janoff, 1980), allowing elastase to generate more EPIs PEPI and SLPI were transiently expressed in HEK293 or COS-1
and perpetuating positive feedback. Eventually, exuda- cells. FLAG-tagged PEPI (aa 18–593) was expressed from pCMV1-
tion of plasma SLPI and the delayed immigration of FLAG and SLPI constructs from pcDNA3.1 (Invitrogene). SLPI con-
structs included mouse full-length (aa 1–131), mouse N-terminalmacrophages (Rappolee and Werb, 1988; Witte and Bar-
domain (aa 1–80), mouse C-terminal domain (aa 1–25/81–131), andbul, 1997) that release copious SLPI and PEPI push the
human full-length (aa 1–131). Three days following cotransfectionPEPI-EPI equilibrium back toward PEPI. PEPI prevents
via SuperFect reagent (Qiagen), conditioned media were immuno-neutrophils from discharging cytotoxic, SLPI-inactivat- precipitated with FLAG M2 antibody (Sigma), separated by reducing
ing oxidants and PEPI-digesting proteinases and drives SDS-PAGE, and Western blotted with anti-SLPI antibody (Jin et al.,
epithelial cells into cycle. In such a manner, the interac- 1997). For in vitro immunoprecipitation assays, recombinant human
tion of SLPI with PEPI could coordinate the innate im- PEPI or EPI (FLAG-tagged) and SLPI (5 pmol each) were incubated
in 10 mM Tris-HCl [pH 7.5], 150 mM NaCl at 37C for 30 min beforemune response with the healing of wounds.
immunoprecipitation with anti-FLAG M2 antibody and Western blot-The foregoing model is strongly supported by the find-
ting with anti-SLPI antibody or the reverse.ing that exogenous PEPI was as effective as exogenous
BAL fluids were collected from healthy adult subjects according to
SLPI in overcoming the defect in wound healing of SLPI an institutional review board approved protocol following informed
null mice. These findings suggest that one major conse- consent. The fluids (45 ml each) were concentrated to 0.5 ml in a
quence of SLPI deletion appears to be a relative defi- Centriprep (Millipore) with 10 kDa cut off before immunoprecipitation
ciency of intact PEPI. Of the molecules protected by with antiserum against human PEPI and Western blotting with anti-
sera against human SLPI or human PEPI.SLPI, PEPI appears to be one of the more important for
Recombinant mouse PEPI purified via FLAG M2 antibody affinitytimely healing of a wound. It will be of interest to estab-
column was subjected to digestion by human neutrophil elastaselish if and how PEPI interacts with other inflammation-
(Sigma) in 100 mM Tris-HCl [pH 8.3] and 960 mM NaCl (Kramps et al.,
derived molecules affected by deletion of SLPI to influ- 1983); human neutrophil cathepsin G (Calbiochem-Novabiochem) in
ence the healing cascade. Our observations may also 100 mM Tris-HCl [pH 7.5], 20 mM MgCl2, 1% DMSO (Rehault et al.,
help to explain why delivery of aerosolized SLPI to cystic 1999); bovine pancreatic -chymotrypsin (Sigma) in 100 mM Tris-
HCl [pH 7.5] and 10 mM CaCl2 (DelMar et al., 1979); or bovine pancre-fibrosis patients suppresses the expression of IL-8 by
Cell
876
atic trypsin (Sigma) in 100 mM Tris-HCl [pH 7.8] and 20 mM CaCl2 Wounds were biopsied at day 3 and bisected perpendicular to the
long axis for RNA extraction and histology. The haematoxylin and(Somorin et al., 1979) at 37C. For determination of the cleavage
sites, recombinant human PEPI (35 g) was incubated with elastase eosin stained cross-section was quantified for the width of the epi-
thelial gap (Adobe Photoshop 5.5) and for the wound area (Meta-at 37C for 18 hr. The products were separated by reducing SDS-
PAGE and transferred to a PVDF membrane (Bio-Rad) and stained Morph4.6, Universal Imaging Co.), defined by the inflammatory re-
gion under the scar, above the muscle and fat layers, and flankedwith Commassie blue. Bands were excised for Edman degradation,
as described (Tempst et al., 1994). by the wound edges. Northern blot was probed with a mouse PEPI
and SLPI ORF cDNA fragment.
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